| | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2023 ( Subtotal = $588,810 ) |
| 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 001 | 6 | 8/16/2023 | NON-COMPETING CONTINUATION | $588,810 |
| 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 000 | 2 | 5/15/2023 | NON-COMPETING CONTINUATION | $0 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2022 ( Subtotal = $563,826 ) |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 003 | 5 | 8/18/2022 | NON-COMPETING CONTINUATION | $11,277 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 002 | 5 | 8/16/2022 | NON-COMPETING CONTINUATION | $552,550 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 000 | 3 | 6/8/2022 | NON-COMPETING CONTINUATION | -$582,930 |
| 2022 | 2021 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 001 | 4 | 6/8/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $582,929 |
| 2022 | 2021 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 006 | 4 | 9/6/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $170,627 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 005 | 3 | 9/6/2022 | NON-COMPETING CONTINUATION | -$1 |
| 2022 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 004 | 2 | 9/6/2022 | NON-COMPETING CONTINUATION | -$170,626 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2021 ( Subtotal = $582,931 ) |
| 2021 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 000 | 3 | 9/3/2021 | NON-COMPETING CONTINUATION | $582,931 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2020 ( Subtotal = $566,520 ) |
| 2020 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 000 | 2 | 8/18/2020 | NON-COMPETING CONTINUATION | $566,520 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2019 ( Subtotal = $566,361 ) |
| 2019 | 2019 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 000 | 1 | 9/13/2019 | NEW | $566,361 |
|
|